This is an Application Brief and does not contain a detailed Experimental section.
This application brief demonstrates analysis of naltrexone using Symmetry Shield RP8 Column.
The compounds used in this study was -
USP Tailing Factors
1. 1.05
2. 1.04
            
        | 
                     Column:  | 
                     Symmetry Shield RP8, 3.9 x 150 mm, 5 μm  | 
            
| 
                     Part number:  | 
                     WAT200655  | 
            
| 
                     Mobile phase:  | 
                     100 mM Ammonium acetate, pH 5.0/acetonitrile 88:12  | 
            
| 
                     Flow rate:  | 
                     1.0 mL/min  | 
            
| 
                     Injection volume:  | 
                     35 μL (500 μL eluate)  | 
            
| 
                     Detection:  | 
                     UV @ 281 nm  | 
            
            
        WA31763.106, June 2003